chr12-2679735-G-A
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_000719.7(CACNA1C):c.5383G>A(p.Gly1795Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00285 in 1,604,226 control chromosomes in the GnomAD database, including 120 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000719.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.5617G>A | p.Gly1873Arg | missense_variant | 44/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.5350G>A | p.Gly1784Arg | missense_variant | 41/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.5548G>A | p.Gly1850Arg | missense_variant | 43/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.5527G>A | p.Gly1843Arg | missense_variant | 44/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.5506G>A | p.Gly1836Arg | missense_variant | 42/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.5473G>A | p.Gly1825Arg | missense_variant | 42/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.5473G>A | p.Gly1825Arg | missense_variant | 42/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.5473G>A | p.Gly1825Arg | missense_variant | 42/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.5473G>A | p.Gly1825Arg | missense_variant | 42/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.5467G>A | p.Gly1823Arg | missense_variant | 43/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.5458G>A | p.Gly1820Arg | missense_variant | 43/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.5443G>A | p.Gly1815Arg | missense_variant | 43/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.5440G>A | p.Gly1814Arg | missense_variant | 42/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.5440G>A | p.Gly1814Arg | missense_variant | 42/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.5440G>A | p.Gly1814Arg | missense_variant | 42/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.5434G>A | p.Gly1812Arg | missense_variant | 42/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.5425G>A | p.Gly1809Arg | missense_variant | 42/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.5407G>A | p.Gly1803Arg | missense_variant | 41/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.5407G>A | p.Gly1803Arg | missense_variant | 41/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.5401G>A | p.Gly1801Arg | missense_variant | 41/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.5383G>A | p.Gly1795Arg | missense_variant | 42/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.5374G>A | p.Gly1792Arg | missense_variant | 42/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.5350G>A | p.Gly1784Arg | missense_variant | 41/46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes AF: 0.0148 AC: 2254AN: 152142Hom.: 62 Cov.: 33
GnomAD3 exomes AF: 0.00368 AC: 835AN: 226606Hom.: 24 AF XY: 0.00287 AC XY: 354AN XY: 123184
GnomAD4 exome AF: 0.00159 AC: 2306AN: 1451966Hom.: 57 Cov.: 34 AF XY: 0.00137 AC XY: 985AN XY: 721406
GnomAD4 genome AF: 0.0148 AC: 2261AN: 152260Hom.: 63 Cov.: 33 AF XY: 0.0147 AC XY: 1092AN XY: 74444
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 07, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Long QT syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at